Healthcare

BPH Global Limited (ASX:BP8) is reshaping its operating focus around seaweed trading and related health and consumer applications. The company has moved away from its former China bird’s nestBusinessand is building activity around seaweed supply, exports andDownstreamproduct development.

Tali Digital Limited (ASX:TD1) is a digital-health company developing software-based tools for cognitive assessment and attentionTrainingin children. ItsBusinesschallenge is to translate research and product development into commercial use,Revenueand broader market adoption.

Audeara Limited (ASX:AUA) develops personalised audio products designed around individual hearing profiles. The company operates at the intersection of consumer audio and hearing health, with products spanning headphones, earbuds, TV listening and technology partnerships.

Invion Limited (ASX:IVX) is a clinical-stage biotechnology company developing the Photosoft photodynamic therapy platform for cancer and other potential indications. Cancer research remains central to its development programme, with clinical progress determining the next stages of the platform.

Tissue Repair Ltd (ASX:TRP) is a biotechnology company developing wound-healing products across clinical and commercial markets. Its lead drug candidate TR987 is being developed for chronic wounds, while TR Pro+ targets skincare and aftercare applications using the company’s Glucoprime technology.

• The indication covers adults and paediatric patients aged one month and older.

The company designs, develops and distributes nurse-call systems andAssistive Technologyhardware and software for healthcare environments, including hospitals, aged care facilities, disability care providers and supported independent living settings.